Mild Cognitive Impairment (MCI) clinical trials
228 active trials name this condition (recorded in the registry as “Mild cognitive disorder”) . Describe your situation to see which ones look like a fit.
Refine by biomarker
By location
- Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
- Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Digital Tools to Support Healthcare Decision Making
- CBD for Individuals at Risk for Alzheimer's Disease
- Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
- Telehealth-Adapted Compensatory Training and Intervention for Cognition
- Using Light Therapy for Mild Cognitive Impairment
- IHT for Mild Cognitive Impairment
- Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- Memory Support System for Older Chinese Americans With Mild Cognitive Impairment
- tDCS for Post-Stroke Cognitive Impairment
- Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
- The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
- Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
- Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI
- Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
- BID WM Digital Intervention in Aging
- Dual Task Perturbation Training for OAwMCI
- Race-Based Stress and Cognitive Training for MCI
- Music Therapy for Patients With Alzheimer's Disease
- Stem Cell Therapy for Early Alzheimer's Disease
- Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
- rTMS to Improve Cognition in Parkinson's
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
- Mindfulness for Cognition in Early-stage Alzheimer's Disease
- ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
- Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
- Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
- Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
- Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
- Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
- Olfactory Training in Mild Cognitive Impairment
- A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI
- Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
- Transcranial Magnetic Stimulation for MCI
- Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Engage for Late-Life Depression and Comorbid Executive Dysfunction
- Multimodal Investigation of Neural Plasticity
- Innate Immunity Stimulation Via TLR9 in Early AD
- Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
- Multi-session Transcranial Alternating Current Stimulation to Improve Dual-task Standing and Brain Activity in Older Adults With Mild Cognitive Impairment
- Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
- Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
- A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- BID LTM Digital Intervention in Aging
- Home Sleep Therapy for Older Adults With MCI
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Mild cognitive disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.